A proposed Medicare reimbursement change could reshape hospital drug pricing
The Trump administration is proposing a rule to prevent hospitals in the 340B program from billing insurers above discounted drug costs for Medicare patients, aiming to save $1.1 billion annually. The rule targets hospitals that currently markup drug prices, which could reduce patient costs but may also impact hospital revenues and services.
Mentioned
Related Signal
Adjacent reporting
- Trump administration proposes a rule it says could save Medicare patients $1.1 billion on drugs
- Trump administration proposes a rule it says could save Medicare patients $1.1 billion on drugs
- STAT+: Cassidy proposes bill to rein in 340B drug discount program
- Trump administration warns more than 500 hospitals to provide more price information or face fines
- STAT+: Congress slashed Medicaid funding to providers. The Trump administration wants to cut even further